PubRank

The use and misuse of transjugular intrahepatic portasystemic shunts.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 10981005)

Published in Curr Gastroenterol Rep on February 01, 2000

Authors

A J Sanyal1

Author Affiliations

1: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical College of Virginia Campus of the Virginia Commonwealth University, MCV Box 980341, Richmond, VA 23298-0341,USA. ajsanyal@hsc.vcu.edu.

Articles citing this ↘

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76

Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol (2004) 1.01

Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol (2006) 0.75